Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.
Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.
复制标题
DOI：
10.1016/j.sapharm.2018.04.002
复制
发表时间：
2019-03
期刊：
影响因子：
--
通讯作者：
Look KA
中科院分区：
文献类型：
--
作者：
Roberts AW;Carpenter DM;Smith A;Look KA
扩大纳洛酮的使用对于减轻美国阿片类药物过量死亡的公共卫生流行至关重要。由于一系列增强的药房纳洛酮准入法，药房现在有更大的独立权力向公众分发纳洛酮。目前还不清楚药剂师需要接受多大程度的专门培训才能担任这一职务。本研究的目的是审查纳洛酮培训任务，从国家加强药房纳洛酮准入法律。使用公开的立法，监管和行政记录完成结构化互联网搜索，以确定增强药房纳洛酮访问法律的类型以及每个州的药剂师纳洛酮培训任务的存在和特征。截至2017年11月22日，所有50个州都实施了加强药房纳洛酮准入法。只有19个州在药剂师从事独立的纳洛酮配药/处方活动之前强制进行有针对性的纳洛酮教育。缺乏对纳洛酮配药药剂师的标准化纳洛酮培训要求可能会影响社区药房采用增强的药房纳洛酮配药实践的比率，以及对有阿片类药物过量风险的患者进行次优教育。确保药剂师准备好作为纳洛酮提供者，对于有意义地防止社区中阿片类药物过量死亡是必要的。
Expanding access to naloxone is crucial for mitigating the public health epidemic of opioid overdose deaths in America. Pharmacists now have greater independent authority to dispense naloxone to the public due to a wave of enhanced pharmacy naloxone access laws. It is unknown to what extent pharmacists are required to receive specialized training to serve in this capacity. The goal of this study was to review naloxone training mandates from states with enhanced pharmacy naloxone access laws. Structured internet searches were completed using publicly available legislative, regulatory, and administrative records to identify the type of enhanced pharmacy naloxone access law and the presence and characteristics of a pharmacist naloxone training mandate in each state. As of November 22, 2017, all 50 states have implemented an enhanced pharmacy naloxone access law. Only 19 states mandated targeted naloxone education before pharmacists engaged in independent naloxone dispensing/prescribing activities. A lack of standardized naloxone training requirements for naloxone-dispensing pharmacists may affect the rate of adoption of enhanced pharmacy naloxone dispensing practices at community pharmacies and suboptimal education of patients at risk of opioid overdose. Ensuring pharmacists’ preparedness to serve as naloxone providers is necessary to meaningfully prevent opioid overdose deaths in their communities.
登录
查看更多内容
DOI：
10.1016/j.japh.2016.12.064
发表时间：
2017-03-01
影响因子：
2.1
作者：
Freeman, Patricia R.;Goodin, Amie;Green, Traci C.
通讯作者：
Green, Traci C.
DOI：
10.1111/add.13326
发表时间：
2016-07
期刊：
Addiction (Abingdon, England)
影响因子：
--
作者：
McDonald R;Strang J
通讯作者：
Strang J
影响因子：
5.5
作者：
Ruhm, Christopher J.
通讯作者：
Ruhm, Christopher J.
DOI：
10.1016/j.japh.2016.12.070
发表时间：
2017-03-01
影响因子：
2.1
作者：
Thornton, J. Douglas;Lyvers, Elizabeth;Dwibedi, Nilanjana
通讯作者：
Dwibedi, Nilanjana
DOI：
10.1056/nejmra1202561
发表时间：
2012-07-12
期刊：
The New England journal of medicine
影响因子：
--
作者：
Boyer EW
通讯作者：
Boyer EW